— Title to Go Here

— Title to Go Here

— Cortisol Discussion Can we harmonise clinical decision limits ? Ronda Greaves Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions JCTLM database Certified Reference Material = 6 Reference Measurement Procedure Reference Lab Steroid Pathway Annals of Clin Biochem 2017;54(3):308-322 CAH - 21OHase Deficiency Pharmacokinetics of cortisol replacement drugs Hydrocortisone Well absorbed, Tmax=1 hour Half life 90-100 minutes (1.5 hours) Lasts for 6-8 hours Prednisolone Rapid and well absorbed (Tmax=1-2hrs) Half-life 2-4 hours Lasts for 10-20 hours Dexamethasone Half life 2.8-7.5 hours in 8-16 yr olds, up to 9.5 hours in <2 year olds Lasts for 15-36 hours, 48 hours in < 2 year olds Slide provided by Dr Jeff Kao Micromedex database 2014 New Review Article Annals of Clin Biochem 2017;54(3):308-322 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions RCPAQAP data – end of 2016 Target set using RMP Instrument Abbreviation n Abbott A 35 Beckman B 13 Ortho O Roche R 47 Siemens S-C 24 Siemens S-I 9 Mass Spec MS 2 2016 Abbott 2016 Beckman 2016 Roche 2016 Siemens - 13 2016 Siemens - 20 2016 Sample Prep / LC-MS/MS Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions Traceability Vitros – “traceable to in-house reference calibrators which have been value assigned to correlate to samples measured by GC-MS” Annals of Clin Biochem 2017;54(3):308-322 Cross-reactivity with cortisol v1 COBAS Electrochemiluminescence Immunoassay (ECLIA) For the antibody derivate used, the following cross- reactivities (%) were found: substance added per 10 μg/mL: cortisol-21-sulfate 0.04 cortisone 0.30 dexamethasone 0.08 prednisone 0.28 substance added per 0.1 μg/mL: prednisolone 171 6-α-methylprednisolone 389 E.g. If a patient is taking prednisolone, then for every 0.1 mcg/mL of prednisolone, there is 171% cross-reactivity i.e. 0.17 ug/mL of the “cortisol” level is prednisolone Change to cortisol methods 20 RMIT University©2015 Changes to standardisation approach Cortisol I Cortisol II 21 RMIT 2015 Vietnam CPC University©2015 Cross Reactivity Table Instrument A B O R S-C S-I MS 11 beta hydroxyprogesterone 0.2 2.52 1 11 beta OH A 0 11 beta OH E 0 11 keto A 0 11 keto E 1.8 11-deoxycorticosterone 0 0.91 0.035 0.227 1.8 0 11-deoxycortisol 1.9 17.8 0.95 3.62 23.3 0 17 alpha OHP 0.6 5.33 0.553 0 1.2 0 Instrument A B O 17 OH pregnanoloneR 0.1S-C S-I 0 MS 20 alpha dihydrocortisol 0.5 20 alpha dihydrocortisone 0.2 11-deoxycorticosterone 0 0.91 0.03520 beta dihydrocortisol 0.227 1.8 1.3 0 20 beta dihydrocortisone 0 11-deoxycortisol 1.9 17.8 0.9521 deoxycortisol 3.62 23.3 0.515 8.1 0 0 6 beta OH cortisol 0.2 6.8 6-alpha-methylprednisolone 0.1 5.94 14.7 26.2 17 alpha OHP 0.6 5.33 0.553Aldosterone 0 0 1.2 0.3 0 0 allo-THF 6.5 17 OH pregnanolone 0.1 Alpha cortol 0 0 Alpha cortolone 0 Androstenedione 0 0 21 deoxycortisol Beclomethasone 0.515 0 8.1 0 Beta cortol 0 0.006 0 6 beta OH cortisol 0.2 Beta cortolone 0 6.80 0 beta sitosterol 0 Betamethasone 0 6-alpha-methylprednisolone 0.1 5.94Budesonide 14.7 0 26.2 Canrenone 0.3 Cortisone 2.7 8.06 0.13Canrenone 4.68 0 31.1 0 Corticosterone 0.9 2.08 1.03 1.29 5.3 8.6 cortisol 21 glucuronide 0.2 Dexamethasone 0 0.04 0.244Cortisone 02.7 8.06 0.20.13 4.68 31.1 0 0 Dehydrocorticosterone 1.9 Dexamethasone 0 0.04 0.244 0 0.2 0 Fludrocortisone 36.6 3.85DHEA 0 0 0.2 DHEAS 0 0 Prednisolone 12.3 23.92 26.8estradiol 7.32 0 109 49 Estriol 0 0.006 0 Estrone 0 0 Prednisone 0.6 3.05 0.076Fludrocortisone 2.3336.6 3.8534 0 5.90.2 Fluticasone 0 0 Medroxyprogesterone 0 Methotrexate 0 Methylprednisolone 21 Mornetasone 0 Prednisolone 12.3 23.92 26.8 7.32 109 49 Prednisone 0.6 3.05 0.076 2.33 34 5.9 Pregnanediol 0 0 Pregnanetriol 0 0 Pregnenolone 0 0.5 Progesterone 0 0.46 0.459 0 0 0 Spirolactone 0 0 0 Testosterone 0 0.007 0.2 tetracycline 0 THE 0.1 0.3 0 THF 0.5 0.159 0 0.9 THS 0 Topiramate 0 Triamicinolone 0.5 0.022 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions 8am RI from package inserts 700 600 500 400 lower RI nmol/L Upper RI 300 200 100 0 Abbott Beckman Ortho Roche Siemens - C Siemens - I Mass Spec 8am cortisol RI Package Insert RCPAQAP RI survey n Low High A 0 B 1 140 640 O 1 172 497 R 14 142 539 S-C 3 220 660 S-I 1 100 540 RCPAQAP RI survey 2016 All labs Roche 800 700 700 600 600 500 500 400 Lower Low nmol/L nmol/L 400 Upper High 300 300 200 200 100 100 0 0 Published Adult LC-MS/MS RI LC-MS/MS Published RI Male Female What does Graham say ? http://www.sydpath.stvincents.com.au/spec_db/ 29 RMIT University© Clinical Biochemistry 1 Post Synacthen lower RI Annals of Clin Biochem 2017;54(3):308-322 Agenda - Information Collated 1) Background 2) RCPAQAP data (from 2016) 3) Kit inserts 4) Reference intervals 5) Questions Questions What are the areas we can agree on ? • Age • Gender • Instrument specific RI • Critical low level Can we improve the traceability information in our kit inserts ?.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    32 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us